Publication | Closed Access

Polyamidoamine dendrimers-based nanomedicine for combination therapy with siRNA and chemotherapeutics to overcome multidrug resistance

NanomedicineNanotherapeuticsEngineeringPolymer-drug ConjugateMedicinePolyamidoamine Dendrimers-based NanomedicineMultidrug ResistancePharmaceutical NanotechnologyNano-drug DeliveryPharmacotherapyCombination TherapyBiomedical EngineeringDrug Delivery SystemPharmacologyDrug Resistance